Quantifying the burden of disease and perceived health state in patients with hereditary angioedema in Sweden.
about
The Humanistic, Societal, and Pharmaco-economic Burden of Angioedema.Canadian hereditary angioedema guideline.Safety, pharmacokinetics, and pharmacodynamics of avoralstat, an oral plasma kallikrein inhibitor: phase 1 study.Socioeconomic burden of hereditary angioedema: results from the hereditary angioedema burden of illness study in Europe.A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in ItalyWheels within wheals: the burden of urticaria and angioedema.C1 inhibitor deficiency: 2014 United Kingdom consensus document.Hereditary Angioedema Due to C1 Inhibitor Deficiency in Serbia: Two Novel Mutations and Evidence of Genotype-Phenotype AssociationEstimation of EuroQol 5-Dimensions health status utility values in hereditary angioedema.High attack frequency in patients with angioedema due to C1-inhibitor deficiency is a major determinant in switching to home therapy: a real-life observational studyProphylaxis in hereditary angioedema (HAE) with C1 inhibitor deficiency.Nanofiltrated C1-esterase-inhibitor in the prophylactic treatment of bradykinin-mediated angioedema.Disorders for which the allergist-immunologist is particularly well-qualified to treat.The asthma-chronic obstructive pulmonary disease overlap syndrome and its challenge for the allergist-immunologist.Insights, strategies, asthma and allergy risk factors, and the allergist/immunologist: Challenges to be met and promises to keep!From the common cough to hereditary angioedema.United airway disease.Disease Severity, Activity, Impact, and Control and How to Assess Them in Patients with Hereditary Angioedema.Health-related quality of life among children with hereditary angioedema.Epidemiology of Bradykinin-mediated angioedema: a systematic investigation of epidemiological studies.Real-world outcomes in hereditary angioedema: first experience from the Icatibant Outcome Survey in the United Kingdom
P2860
Q30249123-ABBFCD57-F83F-4B5B-89A0-D26514BF2284Q30596332-0B8AFACE-A2F6-4627-951E-33D2BB16B448Q33167153-AF9F9C1B-6B53-49BD-904B-E789E19FE33DQ33929615-E1B02CFB-551C-49D2-A93D-7423CF1D9CCDQ35099643-B57FCF59-2844-4EA6-BF2B-E5ACED8E13F4Q35221083-F7C6DDC8-4D01-45A5-9AE6-5DD3CB3CD182Q35667502-C0B109CE-27BF-4398-B2B6-16B42527CE6FQ35831806-F10A2F16-283B-4DF7-8ADF-FD61C128C15AQ37249076-C01EEBF2-DCE6-4D4B-9F41-F828677296C6Q37299151-61EEF42E-A6E0-4DEF-B959-9D6AEA75090CQ38772714-BD7D1886-BEF3-4B85-87D6-7FBFE6F1F6AAQ40117747-44EAE09F-1EAF-40AB-9987-FD2AC4564957Q42592199-E2E35E62-34EF-40E7-AA5B-391DB2EE4A08Q42687136-FB945D76-EC6F-48FF-9376-1C7B36BA4E07Q43101530-9B735157-5D77-4A1E-BB19-AF2CBFD4636BQ43190912-02431D9B-74DE-4435-B871-BA8D2BF24B3FQ43200352-DAC9D97C-265E-4C0C-BC7D-466B1D6E3F68Q47152048-82C41E97-F709-4947-A72C-607369C21C46Q47426091-01B1A626-2539-4A47-A840-210E2E983E9AQ55340027-5D92C6B8-F218-47A6-B957-51AEA1AE5BAFQ58798864-85650037-E181-4688-87D4-32F4CF5FCD58
P2860
Quantifying the burden of disease and perceived health state in patients with hereditary angioedema in Sweden.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Quantifying the burden of dise ...... reditary angioedema in Sweden.
@en
Quantifying the burden of dise ...... reditary angioedema in Sweden.
@nl
type
label
Quantifying the burden of dise ...... reditary angioedema in Sweden.
@en
Quantifying the burden of dise ...... reditary angioedema in Sweden.
@nl
prefLabel
Quantifying the burden of dise ...... reditary angioedema in Sweden.
@en
Quantifying the burden of dise ...... reditary angioedema in Sweden.
@nl
P2093
P356
P1476
Quantifying the burden of dise ...... reditary angioedema in Sweden.
@en
P2093
Anders Lindfors
Carl-Fredrik Wahlgren
Janne Björkander
Lotus Mallbris
Patrik Nordenfelt
Simon Dawson
P304
P356
10.2500/AAP.2014.35.3738
P577
2014-01-09T00:00:00Z